Mattel Inc vs Stryker Corporation — how do they compare? Mattel Inc trades at $14.19 (market cap $4.11B), while Stryker Corporation trades at $319.04 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 29.8× Mattel Inc's market cap, and Stryker Corporation pays a 1% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.
| MAT | SYK | |
|---|---|---|
Market Cap | $4.11B | $122.35B |
Sector | Consumer Cyclical | Technology |
52-Week High | $22.16 | $403.53 |
52-Week Low | $13.05 | $282.58 |
Enterprise Value | $5.92B | $134.10B |
Dividend Yield | — | 1% |
Signals from Pluang's Aura AI — not financial advice
Mattel (MAT) trades at $14.2, down 0.7% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 9.06 and P/S of 0.83, while maintaining solid profitability with a 9.27% net income margin. Recent earnings have been mixed, with a beat in Q1 2026 but misses in prior quarters. The company continues to drive brand engagement through new product launches and collaborations, as highlighted by recent Comic-Con exclusives and partnerships.
The investment outlook is cautiously optimistic, supported by deep-value fundamentals and positive analyst sentiment, but tempered by recent earnings volatility and a negative net cash flow trend. Key opportunities include undervaluation relative to peers and strong brand portfolio; risks involve execution on sales growth and managing debt levels amid economic uncertainties.
Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.
Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.
Trailing returns across standard periods
Latest headlines on both assets
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →